Quantum Biopharma (QNTM) Amortizatization of Intangibles (2024 - 2026)
Quantum Biopharma (QNTM) reported Amortizatization of Intangibles of $13267.0 for Q1 2026, down 95.96% on a YoY basis from $328448.0 in Q1 2025, and down 1.76% sequentially from $13505.0 in Q3 2025.
Quantum Biopharma (QNTM) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 3 years of Amortizatization of Intangibles data on file, last reported at $13267.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 95.96% year-over-year to $13267.0; the trailing twelve-month figure through Mar 2026 stood at $473831.0 (up 45.56% YoY), and the FY2024 full-year result was $14560.0, changed N/A from the prior year.
- Amortizatization of Intangibles retreated to $13267.0 in Q1 2026, from $13505.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $328448.0 in Q1 2025 to a low of -$17476.0 in Q2 2024.
- A 3-year average of $69770.1 and a median of $14560.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles soared 1779.42% in 2025 and tumbled 95.96% in 2026, its largest moves.
- Tracing QNTM's Amortizatization of Intangibles over 3 years: stood at $14560.0 in 2024, then dropped by 7.25% to $13505.0 in 2025, then slipped by 1.76% to $13267.0 in 2026.
- Business Quant data shows QNTM's Amortizatization of Intangibles at $13267.0 in Q1 2026, $13505.0 in Q3 2025, and $118611.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Quantum Biopharma | 13.11 Bn | 13.10 Bn | - | 13,267.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,267.00 |
| Mar 31, 2026 | 13,267.00 |
| Sep 30, 2025 | 13,505.00 |
| Sep 30, 2025 | 13,505.00 |
| Jun 30, 2025 | 118,611.00 |
| Jun 30, 2025 | 118,611.00 |
| Mar 31, 2025 | 328,448.00 |
| Mar 31, 2025 | 328,448.00 |
| Dec 31, 2024 | 14,560.00 |
| Dec 31, 2024 | 14,560.00 |
| Jun 30, 2024 | -17,476.00 |
| Jun 30, 2024 | -17,476.00 |
| Mar 31, 2024 | 17,476.00 |
| Mar 31, 2024 | 17,476.00 |